JPRN-jRCTs041190021
Recruiting
Phase 2
Fecal microbiota transplantation for intractable gastrointestinal diseases(FEMIGI study)
Ohmiya Naoki0 sites50 target enrollmentApril 23, 2019
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- 1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associat
- Sponsor
- Ohmiya Naoki
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\)recipient
- •A patient who provides the informed consent or legally acceptable representatives of whom provide the informed consent
- •with all negative screening tests
Exclusion Criteria
- •(1\)recipient
- •1\) past history of allergy to drugs used in this study
- •2\) possible of documented pregnant women
- •3\) judged to be inappropriate by the investigator
- •1\) person who is not compatible to the selection criteria
- •2\) person with past history of allergy to drugs used in this study
- •3\) possible of documented pregnant women
- •4\) person with suspected or documented bowel obstruction
- •5\) person with gastrointestinal tumors
- •6\) person who was judged to be inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A-FMT for active UCMild to moderate ulcerative colitisUlcerative colitisJPRN-jRCTs031220542agahara Akihito37
Active, not recruiting
Not Applicable
Role of transplantation of fecal microbiota from healthy individuals to patients with Crohn's disease and its effect on achieving control of disease activityCrohn's disease of both small and large intestineDigestive SystemISRCTN15318304Dayanand Medical College & Hospital36
Not yet recruiting
Not Applicable
Fecal microbiota transplantation for eradication of Vancomycin-Resistant EnterococciVancomycin-resistant Enterococci carriageAntibiotic resistanceDragerschap vancomycine-resistente Enterococ Antibiotica resistentieNL-OMON25381niversity Medical Center Utrecht10
Withdrawn
Phase 2
Fecal Microbiota Transplantation for eradication of Vancomycin-resistant Enterococci (FAVOR): a pilot studyCarriage of vancomycin-resistant Enterococvancomycin-resistant Enterococ carrier10004018NL-OMON46675niversitair Medisch Centrum Utrecht10
Completed
Not Applicable
Fecal microbiota transplantation for recurrent Clostridioides difficile infectioRecurrent Clostridioides difficile infectionJPRN-UMIN000042418Shiga University of Medical Science